 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

It's been a busy week for Swiss healthcare giant Novartis. In a series of days, the company said it's slowing trials of its blockbuster cancer drug and slashing hundreds of jobs and attempting to...

Novartis wants to buy a German cancer drugmaker as it stops recruiting for its own trials

Looking At Novartis's Recent Unusual Options Activity

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options...

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Futures On Edge Ahead Of Critical CPI Report

 Futures are up small before the March CPI data was expected to show further moderation in price pressures following stronger readings at the...

Futures On Edge Ahead Of Critical CPI Report

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Novartis announces new data on twice-yearly Leqvio in ASCVD

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stryker (SYK Research Report), Novartis AG (CH:NOV...

Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Novartis AG (Six Swiss: CH:NOVN) and AstraZeneca (GB:AZN)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Shop Apotheke Europe NV (GB:0RJT Research Report), Stryker...

Analysts Offer Insights on Healthcare Companies: Shop Apotheke Europe NV (GB:0RJT), Stryker (SYK) and Novartis AG (Six Swiss: CH:NOVN)

Novartis to file Pluvicto pre-taxane label expansion in 2H 2024 based on Phase 3 PSMAfore study data. Updated overall survival results show HR&lt;1.0 in ITT population. rPFS consistent. Safety...

Why Is Novartis Stock Trading Higher On Thursday?

Novartis: Higher Guidance, Now A Buy

Patten  Patten Inc. TN cut its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 5.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional...

Novartis AG (NYSE:NVS) Shares Sold by Patten & Patten Inc. TN

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Volume (M)	239,326.00
52-Wk High	$108.78
52-Wk Low	$88.90

NVS Novartis AG

About

Feed

News

Sentiment

Earnings

Fundamentals